35 results
6-K
EX-99.2
SPRC
SciSparc Ltd
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
or that the term of such capital raise will be on terms favorable to us. In addition, as we continue to assess the effects of the COVID-19 pandemic and its … 2022 offerings, all of which were during the COVID-19 pandemic, there can be no assurance that we will be able to raise financing again during
6-K
EX-99.2
SPRC
SciSparc Ltd
16 Aug 21
Interim Consolidated Financial Statements
12:00am
raise will be on terms favorable to us. In addition, as we continue to assess the effects of the COVID-19 pandemic and its impact on capital market … the COVID-19 pandemic, there can be no assurance that we will be able to raise financing again during the COVID-19 pandemic, or even after COVID-19
6-K
SPRC
SciSparc Ltd
30 Apr 20
Current report (foreign)
4:26pm
to the impact of the COVID-19 coronavirus pandemic on the business, consultants and service providers of Therapix Biosciences Ltd. (the “Company … conditions surrounding the COVID-19 pandemic spreading throughout the Israel and the world. Tel-Aviv and Givatayim, Israel, where the Company and its
6-K
EX-99.1
SPRC
SciSparc Ltd
25 Sep 20
Special General Meeting of Shareholders
8:12am
on developments with respect to the coronavirus (COVID-19) pandemic, we might hold the Meeting virtually on the above date and time instead … a designated representative on their behalf are asked to follow the instructions of the Israeli authorities regarding the Covid-19 pandemic.
Sincerely
6-K
EX-99.1
SPRC
SciSparc Ltd
9 Oct 20
Interim Consolidated Financial Statements
12:00am
countries has resulted in the World Health Organization declaring the outbreak of COVID-19 as a “pandemic,” or a worldwide spread of a new disease … as to when any of the restrictions will be loosened again.
Due to the impact of the COVID-19 pandemic on the business, consultants and service providers
6-K
EX-99.1
tdajxm mk
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.1
mxzkl34 00iu
2 Dec 20
Special General Meeting of Shareholders
4:02pm
6-K
EX-99.2
ua7l3wv9vp7hv
9 Oct 20
Interim Consolidated Financial Statements
12:00am
6-K
EX-99.2
mril 622jo
25 Sep 20
Special General Meeting of Shareholders
8:12am
6-K
3cdc00r54wbcon631w
31 Jul 20
Report of Foreign Private Issuer
8:42am
6-K
l6k537yae2dg5j jcpx6
14 Oct 20
Current report (foreign)
4:02pm
6-K
EX-99.2
d21m2vvs m2v
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
EX-99.1
kzj6krio xah
28 Apr 20
Current report (foreign)
8:37am
6-K
EX-99.2
ap05wopa
2 Dec 20
Special General Meeting of Shareholders
4:02pm
6-K
EX-99.1
r0zqsmhy 8jn8der
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
EX-99.1
q2u8j 6xp
16 Aug 21
Interim Consolidated Financial Statements
12:00am
6-K/A
EX-99.1
44np47yzdq5
26 Aug 21
Current report (foreign) (amended)
4:42pm